Thyroid cancer trials in Hong Kong

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Where

  Hong Kong, Shatin

  Age

  18 years and over

  People

  554 worldwide

  Run by

  Institut de Recherches Internationales Servier

  See details and how to joinNCT05786924 · EU 2025-523474-16-00
• No phaseEnrolling by invitation
  Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management

  Where

  Hong Kong

  Age

  18 years and over

  People

  76

  Run by

  The University of Hong Kong

  See details and how to joinNCT07234539
• Phase 1/2Taking people
  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Where

  Hong Kong

  Age

  12 years and over

  People

  500 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT03093116 · EU 2024-512606-25-00